Načítá se...

Immunosuppression in inflammatory bowel disease: how much is too much?

PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Opin Gastroenterol
Hlavní autoři: Cohen, Benjamin L., Torres, Joana, déric Colombel, Jean-Fré
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/
https://ncbi.nlm.nih.gov/pubmed/22573191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!